semaglutide strips Multiple GLP-1 drugs linked to lower AFib risk FDA ends shortage of popular

What This New Study Found Between Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and Stroke Risk A new cohort study published July 2025 in JAMA Network Open followed over 60,000 adults with both type 2 diabetes and obesity

Trials focused on obesity have noted an increased risk of gallbladder disease (2-3 %) with GLP-1RAs

We found a decrease in gFA, a metric that can be modulated by myelin integrity but also other factors such as axonal size and volume of water surrounding axons, 83 and we can only speculate about which factor is the most implicated

Some patients find that morning administration rather than evening dosing helps, though there is no clinical evidence that timing significantly affects side effects

Consistency over time matters more than perfect daily adherence